200 related articles for article (PubMed ID: 28430804)
1. Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
Bezan A; Posch F; Ploner F; Bauernhofer T; Pichler M; Szkandera J; Hutterer GC; Pummer K; Gary T; Samonigg H; Beyer J; Winder T; Hermanns T; Fankhauser CD; Gerger A; Stotz M
PLoS One; 2017; 12(4):e0176283. PubMed ID: 28430804
[TBL] [Abstract][Full Text] [Related]
2. Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Terbuch A; Walser G; Stotz M; Gerger A; Posch F; Bauernhofer T
Clin Genitourin Cancer; 2023 Feb; 21(1):24-31. PubMed ID: 36400695
[TBL] [Abstract][Full Text] [Related]
3. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
[TBL] [Abstract][Full Text] [Related]
4. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
Tran B; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Fankhauser C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Garcia Del Muro X; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL
Cancer Med; 2020 Jan; 9(1):116-124. PubMed ID: 31715650
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study.
Abdel-Razeq H; Tamimi F; Abdel-Razeq R; Salah S; Omari Z; Salama O; Abufara A; Al-Tell A; Qahoush H; Nasman A; Taqash A; Alhalaseh Y; Bater R
Clin Appl Thromb Hemost; 2021; 27():10760296211024756. PubMed ID: 34121471
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolic Events in Patients with Testicular Germ Cell Tumours Are Predominantly Triggered by Advanced Disease and by Central Venous Access Systems.
Dieckmann KP; Marghawal D; Pichlmeier U; Wülfing C
Urol Int; 2021; 105(3-4):257-263. PubMed ID: 33333524
[TBL] [Abstract][Full Text] [Related]
7. A venous thromboembolism risk assessment model for patients with Cushing's syndrome.
Zilio M; Mazzai L; Sartori MT; Barbot M; Ceccato F; Daidone V; Casonato A; Saggiorato G; Noventa F; Trementino L; Prandoni P; Boscaro M; Arnaldi G; Scaroni C
Endocrine; 2016 May; 52(2):322-32. PubMed ID: 26113424
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
Gonzalez-Billalabeitia E; Castellano D; Sobrevilla N; Guma J; Hervas D; Luengo MI; Aparicio J; Sanchez-Muñoz A; Mellado B; Saenz A; Valverde C; Fernandez A; Margeli M; Duran I; Fernandez S; Sastre J; Ros S; Maroto P; Manneh R; Cerezuela P; Carmona-Bayonas A; Ayala de la Peña F; Luis Aguilar J; Rivera S; García Del Muro X; Germà-Lluch JR;
J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122896
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's Oncology Group.
Singla N; Wong J; Singla S; Krailo M; Huang L; Shaikh F; Billmire D; Rescorla F; Ross J; Dicken B; Amatruda JF; Lindsay Frazier A; Bagrodia A
J Pediatr Urol; 2022 Aug; 18(4):505-511. PubMed ID: 35606324
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Terbuch A; Posch F; Partl R; Zurl B; Bauernhofer T; Pichler M; Szkandera J; Hutterer GC; Pummer K; Kapp KS; Stöger H; Gerger A; Stotz M
Cancer Med; 2018 Feb; 7(2):508-514. PubMed ID: 29349917
[TBL] [Abstract][Full Text] [Related]
11. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
[TBL] [Abstract][Full Text] [Related]
13. Predictors of venous thromboembolism development before and during chemotherapy for advanced germ cell tumor.
Nitta S; Kawai K; Kimura T; Kawahara T; Kandori S; Hoshi A; Kojima T; Nishiyama H
Jpn J Clin Oncol; 2020 Mar; 50(3):338-343. PubMed ID: 32037439
[TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Stephenson AJ; Bosl GJ; Motzer RJ; Kattan MW; Stasi J; Bajorin DF; Sheinfeld J
J Clin Oncol; 2005 Apr; 23(12):2781-8. PubMed ID: 15837993
[TBL] [Abstract][Full Text] [Related]
15. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Stephenson AJ; Aprikian AG; Gilligan TD; Oldenburg J; Powles T; Toner GC; Waters WB
Urology; 2011 Oct; 78(4 Suppl):S444-55. PubMed ID: 21986224
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism During Chemotherapy for Testicular Cancer: A Population-Based Study.
Robinson AG; Wei X; Karim S; Raphael MJ; Bedard PL; Booth CM
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e188-e193. PubMed ID: 32387044
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.
Stuijver DJ; van Zaane B; Feelders RA; Debeij J; Cannegieter SC; Hermus AR; van den Berg G; Pereira AM; de Herder WW; Wagenmakers MA; Kerstens MN; Zelissen PM; Fliers E; Schaper N; Drent ML; Dekkers OM; Gerdes VE
J Clin Endocrinol Metab; 2011 Nov; 96(11):3525-32. PubMed ID: 21880802
[TBL] [Abstract][Full Text] [Related]
18. Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients.
Pannucci CJ; Obi A; Alvarez R; Abdullah N; Nackashi A; Hu HM; Bahl V; Henke PK
J Am Coll Surg; 2014 May; 218(5):898-904. PubMed ID: 24680577
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
Khorana AA; Dalal M; Lin J; Connolly GC
Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
